Impact of antithrombotic agents on outcomes in patients requiring surgery for chronic subdural haematoma: a systematic review and meta-analysis

References

• Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017;14:108.
   PubMed Web of Science ®Google Scholar
• Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012;35:155–69; discussion 169.
   PubMed Web of Science ®Google Scholar
• Fogelholm R, Heiskanen O, Waltimo O. Chronic subdural hematoma in adults. Influence of patient’s age on symptoms, signs, and thickness of hematoma. J Neurosurg 1975;42:43–6.
   PubMed Web of Science ®Google Scholar
• Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S. Increasing incidence of chronic subdural haematoma in the elderly. QJM 2017;110:375–8.
   PubMed Web of Science ®Google Scholar
• Rauhala M, Luoto TM, Huhtala H, et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg 2019;132:1147–57.
   PubMed Web of Science ®Google Scholar
• Stubbs DJ, Vivian ME, Davies BM, Ercole A, Burnstein R, Joannides AJ. Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta Neurochir (Wien) 2021;163:2629–37.
   PubMed Web of Science ®Google Scholar
• Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 2014;10:570–8.
   PubMed Web of Science ®Google Scholar
• UNO M, TOI H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign? Neurol Med Chir (Tokyo) 2017;57:402–9.
   PubMed Web of Science ®Google Scholar
• Rauhala M, Helén P, Huhtala H, et al. Chronic subdural hematoma-incidence, complications, and financial impact. Acta Neurochir (Wien) 2020;162:2033–43.
   PubMed Web of Science ®Google Scholar
• Gillespie CS, Fung KW, Alam AM, et al. How does research activity align with research need in chronic subdural haematoma: a gap analysis of systematic reviews with end-user selected knowledge gaps. Acta Neurochir (Wien) 2023;165:1975–86.
   PubMed Web of Science ®Google Scholar
• Troy A, Anderson TS. National trends in use of and spending on oral anticoagulants among US medicare beneficiaries from 2011 to 2019. JAMA Health Forum 2021;2:e211693.
   PubMedGoogle Scholar
• Tan C, Cieslik L, Steele S, Warner V, Mariani J, Patel HC. Contemporary trends in antiplatelet prescription in Australia. Pharmacy Practice and Res 2020;50:366–8.
   Google Scholar
• Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 2017;127:732–9.
   PubMed Web of Science ®Google Scholar
• Stubbs DJ, Davies BM, Bashford T, et al. Identification of factors associated with morbidity and postoperative length of stay in surgically managed chronic subdural haematoma using electronic health records: a retrospective cohort study. BMJ Open 2020;10:e037385.
   PubMed Web of Science ®Google Scholar
• Lindvall P, Koskinen LO. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009;16:1287–90.
   PubMed Web of Science ®Google Scholar
• Poon MTC, Rea C, Kolias AG, Brennan PM, British Neurosurgical Trainee Research C. Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021;38:1177–84.
   PubMed Web of Science ®Google Scholar
• Hornor MA, Duane TM, Ehlers AP, et al. American College of Surgeons’ Guidelines for the Perioperative Management of Antithrombotic Medication. J Am Coll Surg 2018;227:521–36.e1.
   PubMed Web of Science ®Google Scholar
• Keeling D, Tait RC, Watson H, British Committee of Standards for Haematology. Peri-operative management of anticoagulation and antiplatelet therapy. Br J Haematol 2016;175:602–13.
   PubMed Web of Science ®Google Scholar
• Chari A, Clemente Morgado T, Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2014;28:2–7.
   PubMed Web of Science ®Google Scholar
• Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J. Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 2017;88:1889–93.
   PubMed Web of Science ®Google Scholar
• Licci M, Kamenova M, Guzman R, Mariani L, Soleman J. Influence of postoperative thrombosis prophylaxis on the recurrence of chronic subdural hematoma after burr-hole drainage. Crit Care Med 2018;46:e26–e32.
   PubMed Web of Science ®Google Scholar
• Stubbs DJ, Davies B, Hutchinson P, Menon DK, Improving Care in Elderly Neurosurgery Initiative (ICENI). Challenges and opportunities in the care of chronic subdural haematoma: perspectives from a multi-disciplinary working group on the need for change. Br J Neurosurg 2022;36:600–8.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang M, Zheng H, et al. The effects of antithrombotic drugs on the recurrence and mortality in patients with chronic subdural hematoma. Medicine (Baltimore))). 2019;98:e13972.
   PubMed Web of Science ®Google Scholar
• Amano T, Matsuo S, Miyamatsu Y, Yamashita S, Nakamizo A. Impact of antithrombotic therapy on surgical treatment in patients with chronic subdural hematoma. J Clin Neurosci 2020;74:55–60.
   PubMed Web of Science ®Google Scholar
• Oh HJ, Seo Y, Choo YH, et al. Clinical characteristics and current managements for patients with chronic subdural hematoma : a retrospective multicenter pilot study in the Republic of Korea. J 2022;65:255–68.
   Google Scholar
• Xu M, Tan W, Wang W, Wang D, Zeng W, Wang C. Minimally invasive surgery in chronic subdural hematoma: prognosis and recurrence factors of 516 cases in a single center. J 2022;11:28.
   Google Scholar
• Younsi A, Riemann L, Habel C, et al. Relevance of comorbidities and antithrombotic medication as risk factors for reoperation in patients with chronic subdural hematoma. Neurosurg Rev 2022;45:729–39.
   PubMed Web of Science ®Google Scholar
• Protocol for the development of a … | Wellcome Open Research. Accessed September 16, 2023. https://wellcomeopenresearch.org/articles/8-390
   Google Scholar
• Kamenova M, Nevzati E, Lutz K, et al. Burr-Hole drainage for chronic subdural hematoma under low-dose acetylsalicylic acid: a comparative risk analysis study. World Neurosurg 2017;100:594–600.
   PubMed Web of Science ®Google Scholar
• Weir B, Gordon P. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections. J Neurosurg 1983;58:242–5.
   PubMed Web of Science ®Google Scholar
• Katano H, Kamiya K, Mase M, Tanikawa M, Yamada K. Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence. J Neurosurg 2006;104:79–84.
   PubMed Web of Science ®Google Scholar
• Hohenstein A, Erber R, Schilling L, Weigel R. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma 2005;22:518–28.
   PubMed Web of Science ®Google Scholar